Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2012
03/08/2012US20120058954 Diaza Heterocyclic Compounds for Phototherapy
03/08/2012US20120058950 Detection of neuropeptides associated with pelvic pain disorders and uses thereof
03/08/2012US20120058949 Methods of Treating Neurological Disorders
03/08/2012US20120058945 Neuroprotective iron chelators and pharmaceutical compositions comprising them
03/08/2012US20120058944 Bone morphogenetic protein 2 (bmp2) variants with reduced bmp antagonist sensitivity
03/08/2012US20120058941 Glucopyranoside compound
03/08/2012US20120058940 Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
03/08/2012US20120058939 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
03/08/2012US20120058937 Prodrugs of Neuraminidase Inhibitors
03/08/2012US20120058487 Compositions and methods for detecting klebsiella pneumoniae
03/08/2012US20120058208 Synergistic Composition for Enhancing Bioavailability of Curcumin
03/08/2012US20120058206 Antiallergic marine biopolymers
03/08/2012US20120058205 Compositions and treatment regimes for reducing inflammation, end-organ injury, and/or systemic endotoxemia
03/08/2012US20120058203 Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2,3-d]pyrimidines
03/08/2012US20120058202 Means and Method for Ovarian Cancer Prognosis
03/08/2012US20120058201 Method of predicting a predisposition to qt prolongation
03/08/2012US20120058199 Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
03/08/2012US20120058194 Pharmaceutical formulations comprising substituted benzimidazole derivatives
03/08/2012US20120058193 Injectable smart gel and method for fabricating the same
03/08/2012US20120058189 Process for making a crystalline zilpaterol salt
03/08/2012US20120058188 Lipid encapsulated interfering rna
03/08/2012US20120058186 Therapeutic or prophylactic agent for dyskinesia
03/08/2012US20120058185 Stable pharmaceutical compositions of olanzapine and process for their preparation
03/08/2012US20120058184 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males
03/08/2012US20120058183 Retigabine tablets, preferably having modified release
03/08/2012US20120058182 Method and composition for administering an nmda receptor antagonist to a subject
03/08/2012US20120058181 Prebiotic Suppositories
03/08/2012US20120058180 Liver-specific Nanocapsules and Methods of Using
03/08/2012US20120058178 Liposome Composition
03/08/2012US20120058177 Nanoparticle-based tumor-targeted drug delivery
03/08/2012US20120058176 Controlled release delivery system for nasal applications and method of treatment
03/08/2012US20120058175 Transdermal Preparation
03/08/2012US20120058174 Fabrication of interconnected model vasculature
03/08/2012US20120058173 Selective starch feeding protocol
03/08/2012US20120058172 Plant extracts for use in brain modulation
03/08/2012US20120058171 Zoo-technical drug delivery device
03/08/2012US20120058170 Drug delivery by carbon nanotube arrays
03/08/2012US20120058161 Alkylated semi synthetic glycosaminoglycosan ethers, and methods for making and using thereof
03/08/2012US20120058160 Particulate materials
03/08/2012US20120058155 Slow-degrading polymers for undelayed and sustained drug delivery
03/08/2012US20120058151 nanoparticulate compositions of poorly soluble compounds
03/08/2012US20120058150 Methods for Delivering Compositions by Electrospraying a Medical Device
03/08/2012US20120058148 Certain aminoalkyl glucosaminide phosphate compounds and their use
03/08/2012US20120058144 Lipids and compositions for the delivery of therapeutics
03/08/2012US20120058133 Inhibition of trna synthetases and therapeutic applications thereof
03/08/2012US20120058130 Compositions and methods for diagnosing, treating, and preventing prostate conditions
03/08/2012US20120058127 PAR2 Agonists for Use in the Treatment or Prevention of Influenza Virus Type A Infections
03/08/2012US20120058123 N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
03/08/2012US20120058121 Methods and compositions for treating lupus
03/08/2012US20120058120 Targets for Growth Factor Signalling and Methods of Therapy
03/08/2012US20120058114 ERBB2 antibodies comprising modular recognition domains
03/08/2012US20120058113 Cancer treatment method
03/08/2012US20120058112 Antibodies
03/08/2012US20120058107 Pyrrolo [3,2-c] pyridine-4-one 2-indolinone protein kinase inhibitors
03/08/2012US20120058106 Novel cancer-associated antigen
03/08/2012US20120058105 Method of treatment of vascular complications
03/08/2012US20120058100 Modulation of drug release rate from electrospun fibers
03/08/2012US20120058099 Use of hypoxanthine for promotion of neuronal outgrowth
03/08/2012US20120058097 Compositions including a sodium channel blocker and a b vitamin molecule and methods of use thereof
03/08/2012US20120058092 Process for the preparation of a composition of genetically modified hematopoietic progenitor cells
03/08/2012US20120058088 Resveratrol-Containing Compositions And Methods Of Use
03/08/2012US20120058087 Diagnosis of endometritis
03/08/2012US20120058085 Deuterium Modified Benzimidazoles
03/08/2012US20120058080 7-Nitro-2-(3-nitro phenyl)-4H-3,1-benzoxazin-4-one or derivatives thereof for treating or preventing antiviral infections
03/08/2012US20120058079 1,2,5-Oxadiazoles as Inhibitors of Indoleamine 2,3-Dioxygenase
03/08/2012US20120058078 Assay for the detection of factors that modulate the expression of ingap
03/08/2012US20120058075 Novel methods for cleaning a surface
03/08/2012US20120058056 Treatment of cutaneous hemangioma
03/08/2012US20120058049 Cromolyn derivatives and related methods of imaging and treatment
03/08/2012DE102010062810A1 2-(R2-Thio)-10-[3-(4-R1-piperazin-1-yl)propyl]-10H-phenothiazine zur Behandlung neurodegenerativer Erkrankungen 2- (R2-thio) -10- [3- (4-R1-piperazin-1-yl) propyl] -10H-phenothiazine for the treatment of neurodegenerative diseases
03/08/2012DE102010040233A1 Bicyclische Aza-Heterocyclen und ihre Verwendung Aza-bicyclic heterocycles and their use
03/08/2012DE102010040187A1 Substituierte N-Phenethyl-triazolonacetamide und ihre Verwendung Substituted N-phenethyl-triazolonacetamide and their use
03/08/2012DE102010040153A1 Stoffkombination zur Behandlung von entzündlichen oder infektiösen Erkrankungen Material combination for the treatment of inflammatory or infectious diseases
03/08/2012CA2847413A1 Vesicular stomatitis viruses
03/08/2012CA2812970A1 Heterocyclyl compounds as histamine h3 receptor ligands
03/08/2012CA2812044A1 Methods of treating bacterial infections through pulmonary delivery of fusidic acid
03/08/2012CA2811864A1 Skin compositions and methods of use thereof
03/08/2012CA2811143A1 Orally administered composition and dietary composition having serum lipid improving effect
03/08/2012CA2810393A1 Method of preparing 3-amino-4-(2-oxo-piperidin-1-yl)-butyric acid derivative for synthesizing medicament
03/08/2012CA2810130A1 Heterocyclic compounds as dgat1 inhibitors
03/08/2012CA2810102A1 Rheumatoid arthritis treatment using polyunsaturated long chain ketones
03/08/2012CA2810092A1 Deuterated analogs of pridopidine useful as dopaminergic stabilizers
03/08/2012CA2810071A1 Substituted tetrahydropyrrolopyrazine derivatives
03/08/2012CA2810049A1 Guanidine compounds and compositions for the inhibition of nampt
03/08/2012CA2810038A1 Novel compounds and compositions for the inhibition of nampt
03/08/2012CA2810024A1 Quinazoline compounds and methods of use thereof
03/08/2012CA2810005A1 Fused tricyclic ether carbamates and their use
03/08/2012CA2810004A1 Crystalline forms of a factor xa inhibitor
03/08/2012CA2809994A1 An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
03/08/2012CA2809993A1 An optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
03/08/2012CA2809991A1 Di-azetidinyl diamide as monoacylglycerol lipase inhibitors
03/08/2012CA2809983A1 Hydrobromide salts of a pyrazolylaminoquinazoline
03/08/2012CA2809958A1 Use of the fetal reprogramming of a ppar ? agonist
03/08/2012CA2809934A1 Process for producing drug-block copolymer composite and pharmaceutical preparation containing same
03/08/2012CA2809911A1 Bicyclic aza heterocycles, and use thereof
03/08/2012CA2809892A1 Pyrazolopyridinone derivatives as lpa receptor antagonists
03/08/2012CA2809836A1 Pyridinones/pyrazinones, method of making, and method of use thereof
03/08/2012CA2809779A1 Fused triazoles for the treatment or prophylaxis of mild cognitive impairment
03/08/2012CA2809716A1 Substituted n-phenethyltriazoloneacetamides and use thereof
03/08/2012CA2809700A1 Adenosine a1 agonists for the treatment of glaucoma and ocular hypertension
1 ... 1323 1324 1325 1326 1327 1328 1329 1330 1331 1332 1333 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 ... 7860